Elevated BCL2 levels are also seen in chronic lymphocytic leukemia (CLL), diffuse large B-cell lymphoma (DLBCL), and acute myeloid leukemia (AML), contributing to poor treatment response [25]. Here, BCL2 is linked to diffuse large B-cell lymphoma.